Advertisement
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
US FDA Web site. Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA). Available at: www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/AnimalMedicinalDrugUseClarificationActAMDUCAof1994/default.htm. Accessed Jul 7, 2009.
-
2.
Payne MA, Baynes RE, Sundlof SE, et al. Drugs prohibited from extralabel use in food animals. J Am Vet Med Assoc 1999;215:28–32.
-
3.
Haskell SR, Payne M, Webb A, et al. Antidotes in food animal practice. J Am Vet Med Assoc 2005;226:884–887.
-
4.
US FDA Web site. ECP not approved for use in animals. Available at: www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm048301.htm. Accessed Jul 7, 2009.
-
5.
Newbold RR. Prenatal exposure to diethylstilbestrol (DES). Fertil Steril 2008;89(suppl 2):e55–e56.
-
6.
Salleras L, Domínguez A, Mata E, et al. Epidemiologic study of an outbreak of clenbuterol poisoning in Catalonia, Spain. Public Health Rep 1995;110:338–342.
-
7.
Barbosa J, Cruz C, Martins J, et al. Food poisoning by clenbuterol in Portugal. Food Addit Contam 2005;22:563–566.
-
8.
Brambilla G, Cenci T, Franconi F, et al. Clinical and pharmacological profile in a clenbuterol epidemic poisoning of contaminated beef meat in Italy. Toxicol Lett 2000;114:47–53.
-
9.
Sporano V, Grasso L, Esposito M, et al. Clenbuterol residues in non-liver containing meat as a cause of collective food poisoning. Vet Hum Toxicol 1998;40:141–143.
-
10.
Center for Food Safety and Applied Nutrition Web site. CVM announces opinion on dipyrone products. Available at: www.foodsafety.gov/∼ear/DIPYRONE.html. Accessed Jul 7, 2009.
-
11.
Extralabel animal drug use; fluoroquinolones and glycopeptides; order of prohibition. Fed Regist 1997;62:27944–27947.
-
12.
Jung WK, Lim JY, Kwon NH, et al. Vancomycin-resistant enterococci from animal sources in Korea. Int J Food Microbiol 2007;113:102–107.
-
13.
Klare I, Konstabel C, Badstübner D, et al. Occurrence and spread of antibiotic resistances in Enterococcus faecium. Int J Food Microbiol 2003;88:269–290.
-
14.
Song JY, Hwang IS, Eom JS, et al. Prevalence and molecular epidemiology of vancomycin-resistant enterococci (VRE) strains isolated from animals and humans in Korea. Korean J Intern Med 2005;20:55–62.
-
15.
US FDA Web site. Reminder—extra-label use of sulfonamides in lactating dairy cattle prohibited. Available at: www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm048401.htm. Accessed Jul 7, 2009.
-
16.
Nelson JM, Chiller TM, Powers JH, et al. Fluoroquinolone-resistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry: a public health success story. Clin Infect Dis 2007;44:977–980.
-
17.
US FDA. Risk assessment on the human health impact of fluoroquinolone resistant Campylobacter associated with the consumption of chicken. Rockville, Md: US FDA, 2001.
-
18.
US FDA Web site. FDA announces final decision about veterinary medicine. Available at: www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2005/ucm108467.htm. Accessed Jul 7, 2009.
-
19.
Price LB, Lackey LG, Vailes R, et al. The persistence of fluoroquinolone-resistant Campylobacter in poultry production. Environ Health Perspect 2007;115:1035–1039.
-
20.
Center for Food Safety and Applied Nutrition Web site. Current information addressing item 15r—drug and chemical control of the grade “A” pasteurized milk ordinance. Available at: www.agmkt.state.ny.us/DI/Newsletters%20and%20Seminar%20info/M-I-06-5%20_M-I-92-10%20Revision-DRUGS_-FINAL.pdf. Accessed Mar 26, 2009.
-
21.
Smith DJ, Paulson GD, Larsen GL. Distribution of radiocarbon after intramammary, intrauterine, or ocular treatment of lactating cows with carbon-14 nitrofurazone. J Dairy Sci 1998;81:979–988.
-
22.
US FDA Web site. FDA prohibits nitrofuran drug use in food-producing animals. Available at: www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm137145.htm. Accessed Jul 7, 2009.
-
23.
US FDA Web site. Compliance policy guide. Section 615.115. Extralabel use of medicated feeds for minor species. Available at: www.fda.gov/ICECI/ComplianceManuals/CompliancePolicyGuidanceManual/ucm074659.htm. Accessed Jul 7, 2009.
-
24.
Phillips I. Withdrawal of growth-promoting antibiotics in Europe and its effects in relation to human health. Int J Antimicrob Agents 2007;30:101–107.
-
25.
Stewart RG, Wyatt RD, Lanza GM, et al. Physiological effects of gentian violet on broiler chickens. Poult Sci 1980;59:234–239.
-
26.
US FDA Web site. FDA veterinarian newsletter 2007 volume XXII, No III. Available at: www.fda.gov/AnimalVeterinary/NewsEvents/FDAVeterinarianNewsletter/ucm055716.htm. Accessed Jul 7, 2009.
-
27.
New animal drugs; phenylbutazone; extralabel animal drug use; order of prohibition. Fed Regist 2003;68:9528–9530.
-
28.
Lees P, Ayliffe T, Maitho TE, et al. Pharmacokinetics, metabolism and excretion of phenylbutazone in cattle following intravenous, intramuscular and oral administration. Res Vet Sci 1988;44:57–67.
-
29.
Smith GW, Davis JL, Tell LA, et al. Extralabel use of nonsteroidal anti-inflammatory drugs in cattle. J Am Vet Med Assoc 2008;232:697–701.
-
30.
US FDA Web site. FDA prohibits use of antiviral drugs in poultry to help keep drugs effective for humans. Available at: www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108620.htm. Accessed Jul 7, 2009.
-
31.
Parry J. Use of antiviral drug in poultry is blamed for drug resistant strains of avian flu. BMJ 2005;331:10.
-
32.
He G, Qiao J, Dong C, et al. Amantadine-resistance among H5N1 avian influenza viruses isolated in Northern China. Antiviral Res 2008;77:72–76.
-
33.
Cyranoski D. China's chicken farmers under fire for antiviral abuse. Nature 2005;435:1009.
-
34.
US FDA Web site. The index of legally marketed unapproved new animal drugs for minor species. Available at: www.fda.gov/AnimalVeterinary/DevelopmentApprovalProcess/MinorUseMinorSpecies/ucm125452.htm. Accessed Jul 7, 2009.
-
35.
US FDA Web site. Product label Ovaprim. Available at: www.fda.gov/AnimalVeterinary/DevelopmentApprovalProcess/MinorUseMinorSpecies/ucm125478.htm. Accessed Jul 7, 2009.
-
36.
US FDA Web site. NARMS executive report, 2005. Available at: www.fda.gov/AnimalVeterinary/SafetyHealth/AntimicrobialResistance/NationalAntimicrobialResistanceMonitoringSystem/ucm093532.htm. Accessed Jul 7, 2009.
-
37.
US FDA Web site. FDA revokes order prohibiting extralabel use of cephalosporin. Available at: www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm054431.htm. Accessed Jul 7, 2009.
-
38.
US FDA Web site. Illegal residues in meat, poultry, seafood, and other animal derived foods. Available at: www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/ComplianceEnforcement/ucm113433.pdf. Accessed Jul 7, 2009.
Advertisement
Update on drugs prohibited from extralabel use in food animals
Extralabel drug use encompasses the use of a drug in an animal in a manner that is not in accordance with the FDA-approved label. This includes use in a species or for a disease or condition not listed on the label; use at dosages, frequencies, or routes of administration that differ from those stated on the label; or deviation from the labeled withdrawal time. Extralabel drug use in veterinary species was made legal by the passage of AMDUCA in 1994.
The information reported here
Contributor Notes
Powered by PubFactory